Maximum quantity allowed is 999
请选择数量
CAS RN: 568-72-9 | 产品编码: T2987
Tanshinone IIA

产品编码 | T2987 |
纯度/分析方法 | >97.0%(HPLC) |
分子式/分子量 | C__1__9H__1__8O__3 = 294.35 |
外观与形状(20°C) | 固体 |
储存温度 | 冷藏 (0-10°C) |
应避免的情况 | 加热 |
包装和容器 | 10MG-Glass Bottle with Plastic Insert (查看图片), 50MG-Glass Bottle with Plastic Insert (查看图片) |
CAS RN | 568-72-9 |
Reaxys-RN | 288781 |
PubChem物质ID | 253659875 |
MDL编号 | MFCD00238692 |
技术规格
Appearance | Orange to Brown powder to crystal |
Purity(HPLC) | min. 97.0 area% |
Melting point | 197.0 to 202.0 °C |
物性(参考值)
熔点 | 198 °C |
GHS
相关法规
RTECS# | SF8282695 |
运输信息
HS编码* | 2932.99-000 |
应用
Tanshinone IIA: A Major Lipophilic Component Extracts from the Root of Salvia miltiorrhiza
Tanshinone IIA, a derivative of phenanthrenequinone, is a major lipophilic component extracts from the root of Salvia miltiorrhiza which is widely used Chinese herbal medicine in treating cardiovascular disease. Biological studies suggested that tanshinone IIA shows a variety of pharmacological activities, such as anticancer, anti-inflammatory, and cardio-cerebrovascular protection activities. (The product is for research purpose only.)
References
- Potential anticancer activity of tanshinone IIA against human breast cancer
- Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis
- Tanshinone IIA inhibits LPS-induced NF- B activation in RAW 264.7 cells: Possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways
- Cardiovascular actions and therapeutic potential of tanshinone IIA (a review)
- Tanshinone II-A: new perspectives for old remedies (a review)
参考文献
文章/手册
TCIMail
产品文档 (部分产品的分析图谱无法提供,敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助,请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注:该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉,您搜索的分析图谱无法提供。